Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Street Walker who wrote (11)	1/28/1999 1:25:00 PM
From: StockMiser	Read Replies (1) \| Respond to of 5582

SW - that's a great point. Allen Gunn's 12 month target is $24 NOT counting the Zicam product, which could easily outsell all of Gumtech's products combined. That certainly reduces risk here. If GUMM never sold a single package of Zicam, it's still at 1/2 the price target. Also very nice knowing that the product is fully developed (not some vaporware hype), and is actually already in test markets.

To: Street Walker who wrote (11)	1/28/1999 3:11:00 PM
From: Bo Didley	Read Replies (3) \| Respond to of 5582

$4.60 Gross /unit of ZICAM by: CapnJon7737 1676 of 1680 I have a retail price on Zicam at $12.95 a unit. ( I had to bribe my grocer at Albertsons w/ a hot stock tip, to get this info, hmmmm). Even at that the numbers I am giving are not cast in stone. The usual mark up on such items is around 80%, 0r a 40% margin; that would give 60% back to Gumm which owms a 60% share in the product. This gives a rough number of $4.66 per unit devolving back to Gumm. Why I took .06 off was to please the shorters.... === my thoughts: If Zicam treats 1% or 2% of the 1 Billion Colds in the US this year alone, this stock will be worth a lot of money. The growth potential for the cold market is phenomenal, particularly if you have the only product that will reduce a cold to 1 1/2 days, rather than enduring a cold for 14 days. bo ps: there are no new shorters in this stock because shares are not borrowable. There are a few very long term shorters who are at yahoo mgs board. They will soon get a big margin call.